Immune Modulation for Cancer Therapy|
The authors review the preclinical and clinical development of ipilimumab. They outline the mode of action of these agents and other immune checkpoint inhibitors, the management of their toxicities, and how to adequately assess response to treatment. [Br J Cancer] Full Article
Visit our reviews page to see a complete list of reviews in the human immunology research field.